tetano
Editor, Senior Moderator
PLoS One
. 2022 Oct 21;17(10):e0269415.
doi: 10.1371/journal.pone.0269415. eCollection 2022.
Influenza vaccination coverage among an urban pediatric asthma population: Implications for population health
Sarah J Parker[SUP] 1 [/SUP], Amy M DeLaroche[SUP] 2 [/SUP], Alex B Hill[SUP] 3 [/SUP], Rajan Arora[SUP] 2 [/SUP], Julie Gleason-Comstock[SUP] 4 [/SUP]
Affiliations
Abstract
Introduction: Asthma is the most common chronic disease in children. Children with asthma are at high risk for complications from influenza; however annual influenza vaccination rates for this population are suboptimal. The overall aim of this study was to describe the characteristics of a high-risk population of children with asthma presenting to an urban pediatric emergency department according to influenza vaccination status.
Methods: The study was a retrospective chart review of 4355 patients aged 2 to 18 years evaluated in a Michigan pediatric emergency department (PED) between November 1, 2017 and April 30, 2018 with an ICD-10-CM code for asthma (J45.x). Eligible patient PED records were matched with influenza vaccination records for the 2017-2018 influenza season from the Michigan Care Improvement Registry. Geospatial analysis was employed to examine the distribution of influenza vaccination status.
Results: 1049 patients (30.9%) with asthma seen in the PED had received an influenza vaccine. Influenza vaccination coverage varied by Census Tract, ranging from 10% to >99%. Most vaccines were administered in a primary care setting (84.3%) and were covered by public insurance (76.8%). The influenza vaccination rate was lowest for children aged 5-11 years (30.0%) and vaccination status was associated with race (p<0.001) and insurance type (p<0.001).
Conclusions: Identification of neighborhood Census Tract and demographic groups with suboptimal influenza vaccination could guide development of targeted public health interventions to improve vaccination rates in high-risk patients. Given the morbidity and mortality associated with pediatric asthma, a data-driven approach may improve outcomes and reduce healthcare-associated costs for this pediatric population.
. 2022 Oct 21;17(10):e0269415.
doi: 10.1371/journal.pone.0269415. eCollection 2022.
Influenza vaccination coverage among an urban pediatric asthma population: Implications for population health
Sarah J Parker[SUP] 1 [/SUP], Amy M DeLaroche[SUP] 2 [/SUP], Alex B Hill[SUP] 3 [/SUP], Rajan Arora[SUP] 2 [/SUP], Julie Gleason-Comstock[SUP] 4 [/SUP]
Affiliations
- PMID: 36269718
- DOI: 10.1371/journal.pone.0269415
Abstract
Introduction: Asthma is the most common chronic disease in children. Children with asthma are at high risk for complications from influenza; however annual influenza vaccination rates for this population are suboptimal. The overall aim of this study was to describe the characteristics of a high-risk population of children with asthma presenting to an urban pediatric emergency department according to influenza vaccination status.
Methods: The study was a retrospective chart review of 4355 patients aged 2 to 18 years evaluated in a Michigan pediatric emergency department (PED) between November 1, 2017 and April 30, 2018 with an ICD-10-CM code for asthma (J45.x). Eligible patient PED records were matched with influenza vaccination records for the 2017-2018 influenza season from the Michigan Care Improvement Registry. Geospatial analysis was employed to examine the distribution of influenza vaccination status.
Results: 1049 patients (30.9%) with asthma seen in the PED had received an influenza vaccine. Influenza vaccination coverage varied by Census Tract, ranging from 10% to >99%. Most vaccines were administered in a primary care setting (84.3%) and were covered by public insurance (76.8%). The influenza vaccination rate was lowest for children aged 5-11 years (30.0%) and vaccination status was associated with race (p<0.001) and insurance type (p<0.001).
Conclusions: Identification of neighborhood Census Tract and demographic groups with suboptimal influenza vaccination could guide development of targeted public health interventions to improve vaccination rates in high-risk patients. Given the morbidity and mortality associated with pediatric asthma, a data-driven approach may improve outcomes and reduce healthcare-associated costs for this pediatric population.